KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer

Keyphrases

• Survival Time 100%
• Pancreatic Cancer 100%
• Cell Cycle Progression 100%
• Pancreatic Tumor 100%
• Tumor Tissue 75%
• Pancreatic Cancer Cells 75%
• Quantitative PCR 50%
• Pancreatic Cancer Cell Lines 50%
• Tumor Formation 50%
• Pancreatic Tumorigenesis 50%
• RNA-protein Complex 25%
• Oncogenesis 25%
• Tissue Sampling 25%
• Reduced Survival 25%
• Reaction Sequence 25%
• Transcription Factor 25%
• Messenger RNA (mRNA) 25%
• Tumor Suppression 25%
• Pancreatic Ductal Adenocarcinoma 25%
• Co-immunoprecipitation (co-IP) 25%
• Metastatic Potential 25%
• Immunohistochemical Analysis 25%
• Reduced Expression 25%
• Cell Tumor 25%
• P27Kip1 25%
• P21Cip1 25%
• Splice Variant 25%
• Polymerase Chain Reaction Analysis 25%
• Xenograft Model 25%
• Human Pancreatic Cancer Cells 25%
• Pancreatic Tissue 25%
• Overall Time 25%
• DNA Sequence Analysis 25%
• Transgenic Expression 25%
• Promoting Growth 25%

Medicine and Dentistry

• Survival Time 100%
• Pancreas Cancer 100%
• Cell Cycle Progression 100%
• Upregulation 100%
• Calcium Ion 100%
• Carcinogenesis 27%
• Cancer Cell 22%
• Pancreas Tumor 22%
• Pancreatic Cancer Cell Line 11%
• Real Time Polymerase Chain Reaction 5%
• Neoplasm 5%
• Xenograft 5%
• Messenger RNA 5%
• Transcription Factor 5%
• Reverse Transcription Polymerase Chain Reaction 5%
• Pancreas Adenocarcinoma 5%
• Metastasis Potential 5%
• DNA Sequence 5%
• Cloning 5%
• Cancer Inhibition 5%
• Immunoprecipitation 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• Calcium Ion 100%
• Survival Time 100%
• Carcinogenesis 27%
• Pancreas Tumor 22%
• Neoplasm 5%
• Messenger RNA 5%
• Transcription Factor 5%
• Immunoprecipitation 5%
• RNA Directed DNA Polymerase 5%
• Metastasis Potential 5%
• Pancreas Adenocarcinoma 5%
• Cancer Inhibition 5%